Logo image of TLC

Taiwan Liposome Company Ltd ADR (TLC) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:TLC -

7
0 (0%)
Last: 9/28/2021, 8:00:01 PM

TLC Key Statistics, Chart & Performance

Key Statistics
Market Cap294.54M
Revenue(TTM)9.91M
Net Income(TTM)-28.93M
Shares42.08M
Float42.08M
52 Week High7.7
52 Week Low4.07
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.69
PEN/A
Fwd PEN/A
Earnings (Next)01-11
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
TLC short term performance overview.The bars show the price performance of TLC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20

TLC long term performance overview.The bars show the price performance of TLC in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of TLC is 7 null. In the past month the price decreased by -2.78%. In the past year, price increased by 59.45%.

Taiwan Liposome Company Ltd ADR / TLC Daily stock chart

TLC Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to TLC. When comparing the yearly performance of all stocks, TLC is one of the better performing stocks in the market, outperforming 84.9% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TLC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TLC. TLC may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TLC Financial Highlights

Over the last trailing twelve months TLC reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS increased by 21.61% compared to the year before.


Industry RankSector Rank
PM (TTM) -291.85%
ROA -60.71%
ROE N/A
Debt/Equity 0.67
Chartmill High Growth Momentum
EPS Q2Q%90.91%
Sales Q2Q%1353.56%
EPS 1Y (TTM)21.61%
Revenue 1Y (TTM)397.16%

TLC Forecast & Estimates

For the next year, analysts expect an EPS growth of 4.76% and a revenue growth -35.08% for TLC


Analysts
Analysts80
Price TargetN/A
EPS Next Y4.76%
Revenue Next Year-35.08%

TLC Ownership

Ownership
Inst Owners0.22%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About TLC

Company Profile

Taiwan Liposome Company Ltd. is a specialty pharmaceutical company. It focuses on development and commercialization of novel nanomedicines designed to target unmet medical need in pain management, ophthalmology and oncology. The company's product pipeline consists of TLC599, TLC590, TLC399 and TLC178 which are in clinical stage. Taiwan Liposome Company Ltd. is headquartered in Taipei City, Taiwan.

Company Info

Taiwan Liposome Company Ltd ADR

11TH FLOOR-1 YUANQU STREET NANGANG DISTRICT

TAIPEI CITY F5 11503

CEO: Keelung Hong

Phone: 886-2-2655-7377

Taiwan Liposome Company Ltd ADR / TLC FAQ

Can you describe the business of Taiwan Liposome Company Ltd ADR?

Taiwan Liposome Company Ltd. is a specialty pharmaceutical company. It focuses on development and commercialization of novel nanomedicines designed to target unmet medical need in pain management, ophthalmology and oncology. The company's product pipeline consists of TLC599, TLC590, TLC399 and TLC178 which are in clinical stage. Taiwan Liposome Company Ltd. is headquartered in Taipei City, Taiwan.


What is the current price of TLC stock?

The current stock price of TLC is 7 null.


What is the dividend status of Taiwan Liposome Company Ltd ADR?

TLC does not pay a dividend.


How is the ChartMill rating for Taiwan Liposome Company Ltd ADR?

TLC has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists TLC stock?

TLC stock is listed on the Nasdaq exchange.


Should I buy TLC stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TLC.